1 / 7

Transforming JDRF Research. Impacting Lives. Julia L . Greenstein, PhD AVP Cure Therapies

Transforming JDRF Research. Impacting Lives. Julia L . Greenstein, PhD AVP Cure Therapies April 10, 2012. JDRF Global Leadership in T1D Research. Largest T1D non-profit: $1.6B in research funded over past 40 years In FY11 JDRF funded: $116 million direct support In 18 countries

mateja
Download Presentation

Transforming JDRF Research. Impacting Lives. Julia L . Greenstein, PhD AVP Cure Therapies

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Transforming JDRF Research.Impacting Lives. Julia L . Greenstein, PhD AVP Cure Therapies April 10,2012

  2. JDRF Global Leadership in T1D Research Largest T1D non-profit: $1.6B in research funded over past 40 years In FY11 JDRF funded: $116 million direct support In 18 countries Including over 50 clinical trials • More than 80% of JDRF expenditures directly support research and research-related education • Forbes magazine called JDRF “...a tightly run organization that puts almost every dollar spent to work curing disease....”

  3. CURING T1D to remove it from the lives of our loved ones Research Agenda of Hope for all T1D Patients • Remains #1 priority for JDRF • Recent explosion of new information about immune system & beta cells • Creating exciting new paths to a cure • Leveraging efforts to both curing & preventing T1D Julia – Cure Importance

  4. Research Agenda of Hope for all T1D Patients • Until we can cure & prevent T1D we are committed to improving lives • The past 40 years have seen significant improvements in care • Translating into longer life expectancy • More can be done to improve the quality of life for everyone living with T1D Aaron – Why Treat? Develop better ways to TREAT T1D allowing a better quality of life

  5. Research Agenda of Hope for all T1D Patients • Growth of T1D is accelerating around the world • Dramatic rise especially among young children • Children born to a family with T1D have a 10 time greater risk of developing the disease • Only prevention can alter this trend and protect future generations from T1D Preventing the autoimmune process from ever starting Stopping and reversing the autoimmune process early to maintain insulin independence

  6. JDRF Research Priorities Regenerating new beta cells Artificial pancreas systems Preventing the autoimmune process from ever starting Encapsulation of alternative beta cell sources Novel insulins and other blood sugar control drugs Stopping and reversing the autoimmune process early to maintain insulin independence Immune therapies Diabetic eye disease Diagnostic, measurement and imaging tools Complications prevention

  7. Give generously to speed JDRF research to cure, better treat and prevent T1D Join a JDRF walk, ride, gala or other fund- raising event Volunteer at your local JDRF chapter Participate in clinical research Make A Difference - Get Involved! Learn more at: jdrf.org

More Related